NFKB1 and COVID-19: Gene set enrichment analysis (GSEA) revealed that 2°BP was characterized by downregulated TNFα signaling via NF-κB in (Fig. 6b, Supplementary Data 4), suggesting that a state of suppressed antibacterial defense might characterize 2°BP in COVID-19 patients.